Patel Quoted on Top Patent Case with Major Pharma Impact

News

Patel Quoted on Top Patent Case with Major Pharma Impact

In The News |

Law360

Sailesh Patel, partner and Intellectual Property Practice Group co-leader, was quoted on Helsinn v. Teva as part of a top ten patent case midyear round-up. The May ruling marked the first time the Federal Circuit interpreted the America Invents Act’s revisions to the on-sale bar rule, which invalidates patents that were used, sold, or generally available to the public before a patent application was filed.

“The on-sale bar is still a potentially strong defense, particularly in the pharmaceutical space.” Sal added that the ruling highlights the importance of confidentiality agreements to keep pharmaceutical companies’ outsourcing agreements and other transactions from becoming public and allowing the rule to be applied.

Read the entire article here. (Subscription needed).